Immunofluorescent staining was performed with polyclonal antibodies to immunolocalize MMP and TIMP proteins in corneal tissue sections from normal control and dry eye mice in situ.
In brief, eyes and adnexa from mice in each group were surgically excised, embedded (OCT compound; VWR, Suwannee, GA), and flash frozen in liquid nitrogen. Sagittal 8-μm sections were cut with a cryostat (model HM 500; Micron, Waldorf, Germany) and placed on glass slides that were stored at −80°C. The tissue sections for immunofluorescent staining were fixed with acetone at −20°C for 5 minutes, then permeabilized with PBS containing 0.1% Triton X-100 for 10 minutes. After blocking with 20% normal horse serum in PBS for 45 to 60 minutes (except for MMP-1 where 20% goat normal serum was used), primary polyclonal goat antibodies against MMPs (Santa Cruz Biotechnology, Santa Cruz, CA; except for MMP-1 where a polyclonal rabbit antibody was used; Chemicon International, Temecula, CA) were applied at a 1:100 dilution and incubated for 1 hour at RT. Secondary antibodies, Alexa-Fluor 488–conjugated goat anti-rabbit IgG or Alexa-Fluor 488–conjugated donkey anti-goat IgG (1:300) was then applied and the sections incubated in a dark chamber for 1 hour, followed by counterstaining with propidium iodide (PI; 2 μg/mL in PBS) for 5 minutes.
Digital confocal images (512 × 512 pixels) were captured with a laser-scanning confocal microscope (LSM 510; with krypton-argon and He-Ne laser; Carl Zeiss Meditec, Inc., Thornwood, NY) with 488-nm excitation and 543-nm emission filters (LP505 and LP560, respectively; Carl Zeiss Meditec, Inc.) and were acquired with a 40/1.3× oil-immersion objective. Samples from untreated control and EDE samples were captured, by using identical photomultiplier tube gain settings, and then were processed (LSM-PC; Carl Zeiss Meditec, Inc.; and Photoshop 7.0 software; Adobe Systems, Mountain View, CA). Staining intensities in the superficial and basal corneal epithelia were graded by consensus of two masked observers who used a previously reported scale; grade 0, no different from the secondary antibody control; +, slightly greater than the secondary antibody control; ++, moderate staining; and +++, intense staining.
37